Quest Diagnostics (0KSX) Stock Overview
Provides diagnostic testing and services in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
0KSX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Quest Diagnostics Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$191.37 |
| 52 Week High | US$198.00 |
| 52 Week Low | US$149.05 |
| Beta | 0.62 |
| 1 Month Change | 3.88% |
| 3 Month Change | 6.26% |
| 1 Year Change | 17.59% |
| 3 Year Change | 30.63% |
| 5 Year Change | 53.34% |
| Change since IPO | 79.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0KSX | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 2.1% | 0.09% | -1.4% |
| 1Y | 17.6% | 20.4% | 13.8% |
Return vs Industry: 0KSX underperformed the UK Healthcare industry which returned 20.5% over the past year.
Return vs Market: 0KSX exceeded the UK Market which returned 13.8% over the past year.
Price Volatility
| 0KSX volatility | |
|---|---|
| 0KSX Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 5.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0KSX has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0KSX's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 50,500 | Jim Davis | www.questdiagnostics.com |
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.
Quest Diagnostics Incorporated Fundamentals Summary
| 0KSX fundamental statistics | |
|---|---|
| Market cap | US$21.28b |
| Earnings (TTM) | US$963.00m |
| Revenue (TTM) | US$10.85b |
Is 0KSX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0KSX income statement (TTM) | |
|---|---|
| Revenue | US$10.85b |
| Cost of Revenue | US$7.22b |
| Gross Profit | US$3.63b |
| Other Expenses | US$2.67b |
| Earnings | US$963.00m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.66 |
| Gross Margin | 33.45% |
| Net Profit Margin | 8.88% |
| Debt/Equity Ratio | 76.9% |
How did 0KSX perform over the long term?
See historical performance and comparisonDividends
Does 0KSX pay a reliable dividends?
See 0KSX dividend history and benchmarks| Quest Diagnostics dividend dates | |
|---|---|
| Ex Dividend Date | Jan 13 2026 |
| Dividend Pay Date | Jan 28 2026 |
| Days until Ex dividend | 49 days |
| Days until Dividend pay date | 64 days |
Does 0KSX pay a reliable dividends?
See 0KSX dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/24 04:44 |
| End of Day Share Price | 2025/11/24 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Quest Diagnostics Incorporated is covered by 37 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Eric Coldwell | Baird |
| Luke Sergott | Barclays |